Medical Care
Global First-in-Human (FIH) Services Market Research Report 2025
- Mar 11, 25
- ID: 18729
- Pages: 96
- Figures: 94
- Views: 20
The global market for First-in-Human (FIH) Services was valued at US$ 654 million in the year 2024 and is projected to reach a revised size of US$ 1298 million by 2031, growing at a CAGR of 11.3% during the forecast period.
First-in-Human Services refer to specialized services that support the planning, execution, and management of First-in-Human (FIH) clinical trials. These services are critical for the successful transition of a drug or therapeutic product from preclinical development to initial testing in human subjects. FIH trials are typically the first time a new drug is administered to humans, making the associated services essential for ensuring safety, compliance, and scientific validity.First-in-Human Services are essential for minimizing risks associated with the early testing of new drugs in humans, ensuring regulatory compliance, and generating reliable data that can influence subsequent phases of drug development. These services help streamline the clinical trial process, improve efficiency, and enhance the likelihood of successful product development.
North American market for First-in-Human (FIH) Services is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for First-in-Human (FIH) Services is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for First-in-Human (FIH) Services in Pharmaceutical Companies is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of First-in-Human (FIH) Services include WuXi AppTec, Allucent, Altasciences, LAXAI, Lonza, Syneos Health, CD BioSciences, Fortrea, Certara, Evotec, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for First-in-Human (FIH) Services, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding First-in-Human (FIH) Services.
The First-in-Human (FIH) Services market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global First-in-Human (FIH) Services market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the First-in-Human (FIH) Services companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
WuXi AppTec
Allucent
Altasciences
LAXAI
Lonza
Syneos Health
CD BioSciences
Fortrea
Certara
Evotec
Aixial Group
Quotient Sciences
Sofpromed
Spaulding Clinical
Biotrial
Crystal Pharmatech Co., Ltd
Avania
Segment by Type
Drugs
Medical Device
Segment by Application
Pharmaceutical Companies
Contract Research Organizations (CROs)
Academic Institutions and Research Centers
Medical Device Companies
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of First-in-Human (FIH) Services company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
First-in-Human Services refer to specialized services that support the planning, execution, and management of First-in-Human (FIH) clinical trials. These services are critical for the successful transition of a drug or therapeutic product from preclinical development to initial testing in human subjects. FIH trials are typically the first time a new drug is administered to humans, making the associated services essential for ensuring safety, compliance, and scientific validity.First-in-Human Services are essential for minimizing risks associated with the early testing of new drugs in humans, ensuring regulatory compliance, and generating reliable data that can influence subsequent phases of drug development. These services help streamline the clinical trial process, improve efficiency, and enhance the likelihood of successful product development.
North American market for First-in-Human (FIH) Services is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for First-in-Human (FIH) Services is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for First-in-Human (FIH) Services in Pharmaceutical Companies is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of First-in-Human (FIH) Services include WuXi AppTec, Allucent, Altasciences, LAXAI, Lonza, Syneos Health, CD BioSciences, Fortrea, Certara, Evotec, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for First-in-Human (FIH) Services, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding First-in-Human (FIH) Services.
The First-in-Human (FIH) Services market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global First-in-Human (FIH) Services market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the First-in-Human (FIH) Services companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
WuXi AppTec
Allucent
Altasciences
LAXAI
Lonza
Syneos Health
CD BioSciences
Fortrea
Certara
Evotec
Aixial Group
Quotient Sciences
Sofpromed
Spaulding Clinical
Biotrial
Crystal Pharmatech Co., Ltd
Avania
Segment by Type
Drugs
Medical Device
Segment by Application
Pharmaceutical Companies
Contract Research Organizations (CROs)
Academic Institutions and Research Centers
Medical Device Companies
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of First-in-Human (FIH) Services company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global First-in-Human (FIH) Services Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Drugs
1.2.3 Medical Device
1.3 Market by Application
1.3.1 Global First-in-Human (FIH) Services Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Pharmaceutical Companies
1.3.3 Contract Research Organizations (CROs)
1.3.4 Academic Institutions and Research Centers
1.3.5 Medical Device Companies
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global First-in-Human (FIH) Services Market Perspective (2020-2031)
2.2 Global First-in-Human (FIH) Services Growth Trends by Region
2.2.1 Global First-in-Human (FIH) Services Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 First-in-Human (FIH) Services Historic Market Size by Region (2020-2025)
2.2.3 First-in-Human (FIH) Services Forecasted Market Size by Region (2026-2031)
2.3 First-in-Human (FIH) Services Market Dynamics
2.3.1 First-in-Human (FIH) Services Industry Trends
2.3.2 First-in-Human (FIH) Services Market Drivers
2.3.3 First-in-Human (FIH) Services Market Challenges
2.3.4 First-in-Human (FIH) Services Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top First-in-Human (FIH) Services Players by Revenue
3.1.1 Global Top First-in-Human (FIH) Services Players by Revenue (2020-2025)
3.1.2 Global First-in-Human (FIH) Services Revenue Market Share by Players (2020-2025)
3.2 Global First-in-Human (FIH) Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by First-in-Human (FIH) Services Revenue
3.4 Global First-in-Human (FIH) Services Market Concentration Ratio
3.4.1 Global First-in-Human (FIH) Services Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by First-in-Human (FIH) Services Revenue in 2024
3.5 Global Key Players of First-in-Human (FIH) Services Head office and Area Served
3.6 Global Key Players of First-in-Human (FIH) Services, Product and Application
3.7 Global Key Players of First-in-Human (FIH) Services, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 First-in-Human (FIH) Services Breakdown Data by Type
4.1 Global First-in-Human (FIH) Services Historic Market Size by Type (2020-2025)
4.2 Global First-in-Human (FIH) Services Forecasted Market Size by Type (2026-2031)
5 First-in-Human (FIH) Services Breakdown Data by Application
5.1 Global First-in-Human (FIH) Services Historic Market Size by Application (2020-2025)
5.2 Global First-in-Human (FIH) Services Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America First-in-Human (FIH) Services Market Size (2020-2031)
6.2 North America First-in-Human (FIH) Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America First-in-Human (FIH) Services Market Size by Country (2020-2025)
6.4 North America First-in-Human (FIH) Services Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe First-in-Human (FIH) Services Market Size (2020-2031)
7.2 Europe First-in-Human (FIH) Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe First-in-Human (FIH) Services Market Size by Country (2020-2025)
7.4 Europe First-in-Human (FIH) Services Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific First-in-Human (FIH) Services Market Size (2020-2031)
8.2 Asia-Pacific First-in-Human (FIH) Services Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific First-in-Human (FIH) Services Market Size by Region (2020-2025)
8.4 Asia-Pacific First-in-Human (FIH) Services Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America First-in-Human (FIH) Services Market Size (2020-2031)
9.2 Latin America First-in-Human (FIH) Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America First-in-Human (FIH) Services Market Size by Country (2020-2025)
9.4 Latin America First-in-Human (FIH) Services Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa First-in-Human (FIH) Services Market Size (2020-2031)
10.2 Middle East & Africa First-in-Human (FIH) Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa First-in-Human (FIH) Services Market Size by Country (2020-2025)
10.4 Middle East & Africa First-in-Human (FIH) Services Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 WuXi AppTec
11.1.1 WuXi AppTec Company Details
11.1.2 WuXi AppTec Business Overview
11.1.3 WuXi AppTec First-in-Human (FIH) Services Introduction
11.1.4 WuXi AppTec Revenue in First-in-Human (FIH) Services Business (2020-2025)
11.1.5 WuXi AppTec Recent Development
11.2 Allucent
11.2.1 Allucent Company Details
11.2.2 Allucent Business Overview
11.2.3 Allucent First-in-Human (FIH) Services Introduction
11.2.4 Allucent Revenue in First-in-Human (FIH) Services Business (2020-2025)
11.2.5 Allucent Recent Development
11.3 Altasciences
11.3.1 Altasciences Company Details
11.3.2 Altasciences Business Overview
11.3.3 Altasciences First-in-Human (FIH) Services Introduction
11.3.4 Altasciences Revenue in First-in-Human (FIH) Services Business (2020-2025)
11.3.5 Altasciences Recent Development
11.4 LAXAI
11.4.1 LAXAI Company Details
11.4.2 LAXAI Business Overview
11.4.3 LAXAI First-in-Human (FIH) Services Introduction
11.4.4 LAXAI Revenue in First-in-Human (FIH) Services Business (2020-2025)
11.4.5 LAXAI Recent Development
11.5 Lonza
11.5.1 Lonza Company Details
11.5.2 Lonza Business Overview
11.5.3 Lonza First-in-Human (FIH) Services Introduction
11.5.4 Lonza Revenue in First-in-Human (FIH) Services Business (2020-2025)
11.5.5 Lonza Recent Development
11.6 Syneos Health
11.6.1 Syneos Health Company Details
11.6.2 Syneos Health Business Overview
11.6.3 Syneos Health First-in-Human (FIH) Services Introduction
11.6.4 Syneos Health Revenue in First-in-Human (FIH) Services Business (2020-2025)
11.6.5 Syneos Health Recent Development
11.7 CD BioSciences
11.7.1 CD BioSciences Company Details
11.7.2 CD BioSciences Business Overview
11.7.3 CD BioSciences First-in-Human (FIH) Services Introduction
11.7.4 CD BioSciences Revenue in First-in-Human (FIH) Services Business (2020-2025)
11.7.5 CD BioSciences Recent Development
11.8 Fortrea
11.8.1 Fortrea Company Details
11.8.2 Fortrea Business Overview
11.8.3 Fortrea First-in-Human (FIH) Services Introduction
11.8.4 Fortrea Revenue in First-in-Human (FIH) Services Business (2020-2025)
11.8.5 Fortrea Recent Development
11.9 Certara
11.9.1 Certara Company Details
11.9.2 Certara Business Overview
11.9.3 Certara First-in-Human (FIH) Services Introduction
11.9.4 Certara Revenue in First-in-Human (FIH) Services Business (2020-2025)
11.9.5 Certara Recent Development
11.10 Evotec
11.10.1 Evotec Company Details
11.10.2 Evotec Business Overview
11.10.3 Evotec First-in-Human (FIH) Services Introduction
11.10.4 Evotec Revenue in First-in-Human (FIH) Services Business (2020-2025)
11.10.5 Evotec Recent Development
11.11 Aixial Group
11.11.1 Aixial Group Company Details
11.11.2 Aixial Group Business Overview
11.11.3 Aixial Group First-in-Human (FIH) Services Introduction
11.11.4 Aixial Group Revenue in First-in-Human (FIH) Services Business (2020-2025)
11.11.5 Aixial Group Recent Development
11.12 Quotient Sciences
11.12.1 Quotient Sciences Company Details
11.12.2 Quotient Sciences Business Overview
11.12.3 Quotient Sciences First-in-Human (FIH) Services Introduction
11.12.4 Quotient Sciences Revenue in First-in-Human (FIH) Services Business (2020-2025)
11.12.5 Quotient Sciences Recent Development
11.13 Sofpromed
11.13.1 Sofpromed Company Details
11.13.2 Sofpromed Business Overview
11.13.3 Sofpromed First-in-Human (FIH) Services Introduction
11.13.4 Sofpromed Revenue in First-in-Human (FIH) Services Business (2020-2025)
11.13.5 Sofpromed Recent Development
11.14 Spaulding Clinical
11.14.1 Spaulding Clinical Company Details
11.14.2 Spaulding Clinical Business Overview
11.14.3 Spaulding Clinical First-in-Human (FIH) Services Introduction
11.14.4 Spaulding Clinical Revenue in First-in-Human (FIH) Services Business (2020-2025)
11.14.5 Spaulding Clinical Recent Development
11.15 Biotrial
11.15.1 Biotrial Company Details
11.15.2 Biotrial Business Overview
11.15.3 Biotrial First-in-Human (FIH) Services Introduction
11.15.4 Biotrial Revenue in First-in-Human (FIH) Services Business (2020-2025)
11.15.5 Biotrial Recent Development
11.16 Crystal Pharmatech Co., Ltd
11.16.1 Crystal Pharmatech Co., Ltd Company Details
11.16.2 Crystal Pharmatech Co., Ltd Business Overview
11.16.3 Crystal Pharmatech Co., Ltd First-in-Human (FIH) Services Introduction
11.16.4 Crystal Pharmatech Co., Ltd Revenue in First-in-Human (FIH) Services Business (2020-2025)
11.16.5 Crystal Pharmatech Co., Ltd Recent Development
11.17 Avania
11.17.1 Avania Company Details
11.17.2 Avania Business Overview
11.17.3 Avania First-in-Human (FIH) Services Introduction
11.17.4 Avania Revenue in First-in-Human (FIH) Services Business (2020-2025)
11.17.5 Avania Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global First-in-Human (FIH) Services Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Drugs
1.2.3 Medical Device
1.3 Market by Application
1.3.1 Global First-in-Human (FIH) Services Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Pharmaceutical Companies
1.3.3 Contract Research Organizations (CROs)
1.3.4 Academic Institutions and Research Centers
1.3.5 Medical Device Companies
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global First-in-Human (FIH) Services Market Perspective (2020-2031)
2.2 Global First-in-Human (FIH) Services Growth Trends by Region
2.2.1 Global First-in-Human (FIH) Services Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 First-in-Human (FIH) Services Historic Market Size by Region (2020-2025)
2.2.3 First-in-Human (FIH) Services Forecasted Market Size by Region (2026-2031)
2.3 First-in-Human (FIH) Services Market Dynamics
2.3.1 First-in-Human (FIH) Services Industry Trends
2.3.2 First-in-Human (FIH) Services Market Drivers
2.3.3 First-in-Human (FIH) Services Market Challenges
2.3.4 First-in-Human (FIH) Services Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top First-in-Human (FIH) Services Players by Revenue
3.1.1 Global Top First-in-Human (FIH) Services Players by Revenue (2020-2025)
3.1.2 Global First-in-Human (FIH) Services Revenue Market Share by Players (2020-2025)
3.2 Global First-in-Human (FIH) Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by First-in-Human (FIH) Services Revenue
3.4 Global First-in-Human (FIH) Services Market Concentration Ratio
3.4.1 Global First-in-Human (FIH) Services Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by First-in-Human (FIH) Services Revenue in 2024
3.5 Global Key Players of First-in-Human (FIH) Services Head office and Area Served
3.6 Global Key Players of First-in-Human (FIH) Services, Product and Application
3.7 Global Key Players of First-in-Human (FIH) Services, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 First-in-Human (FIH) Services Breakdown Data by Type
4.1 Global First-in-Human (FIH) Services Historic Market Size by Type (2020-2025)
4.2 Global First-in-Human (FIH) Services Forecasted Market Size by Type (2026-2031)
5 First-in-Human (FIH) Services Breakdown Data by Application
5.1 Global First-in-Human (FIH) Services Historic Market Size by Application (2020-2025)
5.2 Global First-in-Human (FIH) Services Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America First-in-Human (FIH) Services Market Size (2020-2031)
6.2 North America First-in-Human (FIH) Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America First-in-Human (FIH) Services Market Size by Country (2020-2025)
6.4 North America First-in-Human (FIH) Services Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe First-in-Human (FIH) Services Market Size (2020-2031)
7.2 Europe First-in-Human (FIH) Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe First-in-Human (FIH) Services Market Size by Country (2020-2025)
7.4 Europe First-in-Human (FIH) Services Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific First-in-Human (FIH) Services Market Size (2020-2031)
8.2 Asia-Pacific First-in-Human (FIH) Services Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific First-in-Human (FIH) Services Market Size by Region (2020-2025)
8.4 Asia-Pacific First-in-Human (FIH) Services Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America First-in-Human (FIH) Services Market Size (2020-2031)
9.2 Latin America First-in-Human (FIH) Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America First-in-Human (FIH) Services Market Size by Country (2020-2025)
9.4 Latin America First-in-Human (FIH) Services Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa First-in-Human (FIH) Services Market Size (2020-2031)
10.2 Middle East & Africa First-in-Human (FIH) Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa First-in-Human (FIH) Services Market Size by Country (2020-2025)
10.4 Middle East & Africa First-in-Human (FIH) Services Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 WuXi AppTec
11.1.1 WuXi AppTec Company Details
11.1.2 WuXi AppTec Business Overview
11.1.3 WuXi AppTec First-in-Human (FIH) Services Introduction
11.1.4 WuXi AppTec Revenue in First-in-Human (FIH) Services Business (2020-2025)
11.1.5 WuXi AppTec Recent Development
11.2 Allucent
11.2.1 Allucent Company Details
11.2.2 Allucent Business Overview
11.2.3 Allucent First-in-Human (FIH) Services Introduction
11.2.4 Allucent Revenue in First-in-Human (FIH) Services Business (2020-2025)
11.2.5 Allucent Recent Development
11.3 Altasciences
11.3.1 Altasciences Company Details
11.3.2 Altasciences Business Overview
11.3.3 Altasciences First-in-Human (FIH) Services Introduction
11.3.4 Altasciences Revenue in First-in-Human (FIH) Services Business (2020-2025)
11.3.5 Altasciences Recent Development
11.4 LAXAI
11.4.1 LAXAI Company Details
11.4.2 LAXAI Business Overview
11.4.3 LAXAI First-in-Human (FIH) Services Introduction
11.4.4 LAXAI Revenue in First-in-Human (FIH) Services Business (2020-2025)
11.4.5 LAXAI Recent Development
11.5 Lonza
11.5.1 Lonza Company Details
11.5.2 Lonza Business Overview
11.5.3 Lonza First-in-Human (FIH) Services Introduction
11.5.4 Lonza Revenue in First-in-Human (FIH) Services Business (2020-2025)
11.5.5 Lonza Recent Development
11.6 Syneos Health
11.6.1 Syneos Health Company Details
11.6.2 Syneos Health Business Overview
11.6.3 Syneos Health First-in-Human (FIH) Services Introduction
11.6.4 Syneos Health Revenue in First-in-Human (FIH) Services Business (2020-2025)
11.6.5 Syneos Health Recent Development
11.7 CD BioSciences
11.7.1 CD BioSciences Company Details
11.7.2 CD BioSciences Business Overview
11.7.3 CD BioSciences First-in-Human (FIH) Services Introduction
11.7.4 CD BioSciences Revenue in First-in-Human (FIH) Services Business (2020-2025)
11.7.5 CD BioSciences Recent Development
11.8 Fortrea
11.8.1 Fortrea Company Details
11.8.2 Fortrea Business Overview
11.8.3 Fortrea First-in-Human (FIH) Services Introduction
11.8.4 Fortrea Revenue in First-in-Human (FIH) Services Business (2020-2025)
11.8.5 Fortrea Recent Development
11.9 Certara
11.9.1 Certara Company Details
11.9.2 Certara Business Overview
11.9.3 Certara First-in-Human (FIH) Services Introduction
11.9.4 Certara Revenue in First-in-Human (FIH) Services Business (2020-2025)
11.9.5 Certara Recent Development
11.10 Evotec
11.10.1 Evotec Company Details
11.10.2 Evotec Business Overview
11.10.3 Evotec First-in-Human (FIH) Services Introduction
11.10.4 Evotec Revenue in First-in-Human (FIH) Services Business (2020-2025)
11.10.5 Evotec Recent Development
11.11 Aixial Group
11.11.1 Aixial Group Company Details
11.11.2 Aixial Group Business Overview
11.11.3 Aixial Group First-in-Human (FIH) Services Introduction
11.11.4 Aixial Group Revenue in First-in-Human (FIH) Services Business (2020-2025)
11.11.5 Aixial Group Recent Development
11.12 Quotient Sciences
11.12.1 Quotient Sciences Company Details
11.12.2 Quotient Sciences Business Overview
11.12.3 Quotient Sciences First-in-Human (FIH) Services Introduction
11.12.4 Quotient Sciences Revenue in First-in-Human (FIH) Services Business (2020-2025)
11.12.5 Quotient Sciences Recent Development
11.13 Sofpromed
11.13.1 Sofpromed Company Details
11.13.2 Sofpromed Business Overview
11.13.3 Sofpromed First-in-Human (FIH) Services Introduction
11.13.4 Sofpromed Revenue in First-in-Human (FIH) Services Business (2020-2025)
11.13.5 Sofpromed Recent Development
11.14 Spaulding Clinical
11.14.1 Spaulding Clinical Company Details
11.14.2 Spaulding Clinical Business Overview
11.14.3 Spaulding Clinical First-in-Human (FIH) Services Introduction
11.14.4 Spaulding Clinical Revenue in First-in-Human (FIH) Services Business (2020-2025)
11.14.5 Spaulding Clinical Recent Development
11.15 Biotrial
11.15.1 Biotrial Company Details
11.15.2 Biotrial Business Overview
11.15.3 Biotrial First-in-Human (FIH) Services Introduction
11.15.4 Biotrial Revenue in First-in-Human (FIH) Services Business (2020-2025)
11.15.5 Biotrial Recent Development
11.16 Crystal Pharmatech Co., Ltd
11.16.1 Crystal Pharmatech Co., Ltd Company Details
11.16.2 Crystal Pharmatech Co., Ltd Business Overview
11.16.3 Crystal Pharmatech Co., Ltd First-in-Human (FIH) Services Introduction
11.16.4 Crystal Pharmatech Co., Ltd Revenue in First-in-Human (FIH) Services Business (2020-2025)
11.16.5 Crystal Pharmatech Co., Ltd Recent Development
11.17 Avania
11.17.1 Avania Company Details
11.17.2 Avania Business Overview
11.17.3 Avania First-in-Human (FIH) Services Introduction
11.17.4 Avania Revenue in First-in-Human (FIH) Services Business (2020-2025)
11.17.5 Avania Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global First-in-Human (FIH) Services Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Drugs
Table 3. Key Players of Medical Device
Table 4. Global First-in-Human (FIH) Services Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global First-in-Human (FIH) Services Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global First-in-Human (FIH) Services Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global First-in-Human (FIH) Services Market Share by Region (2020-2025)
Table 8. Global First-in-Human (FIH) Services Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global First-in-Human (FIH) Services Market Share by Region (2026-2031)
Table 10. First-in-Human (FIH) Services Market Trends
Table 11. First-in-Human (FIH) Services Market Drivers
Table 12. First-in-Human (FIH) Services Market Challenges
Table 13. First-in-Human (FIH) Services Market Restraints
Table 14. Global First-in-Human (FIH) Services Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global First-in-Human (FIH) Services Market Share by Players (2020-2025)
Table 16. Global Top First-in-Human (FIH) Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in First-in-Human (FIH) Services as of 2024)
Table 17. Ranking of Global Top First-in-Human (FIH) Services Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by First-in-Human (FIH) Services Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of First-in-Human (FIH) Services, Headquarters and Area Served
Table 20. Global Key Players of First-in-Human (FIH) Services, Product and Application
Table 21. Global Key Players of First-in-Human (FIH) Services, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global First-in-Human (FIH) Services Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global First-in-Human (FIH) Services Revenue Market Share by Type (2020-2025)
Table 25. Global First-in-Human (FIH) Services Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global First-in-Human (FIH) Services Revenue Market Share by Type (2026-2031)
Table 27. Global First-in-Human (FIH) Services Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global First-in-Human (FIH) Services Revenue Market Share by Application (2020-2025)
Table 29. Global First-in-Human (FIH) Services Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global First-in-Human (FIH) Services Revenue Market Share by Application (2026-2031)
Table 31. North America First-in-Human (FIH) Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America First-in-Human (FIH) Services Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America First-in-Human (FIH) Services Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe First-in-Human (FIH) Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe First-in-Human (FIH) Services Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe First-in-Human (FIH) Services Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific First-in-Human (FIH) Services Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific First-in-Human (FIH) Services Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific First-in-Human (FIH) Services Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America First-in-Human (FIH) Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America First-in-Human (FIH) Services Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America First-in-Human (FIH) Services Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa First-in-Human (FIH) Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa First-in-Human (FIH) Services Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa First-in-Human (FIH) Services Market Size by Country (2026-2031) & (US$ Million)
Table 46. WuXi AppTec Company Details
Table 47. WuXi AppTec Business Overview
Table 48. WuXi AppTec First-in-Human (FIH) Services Product
Table 49. WuXi AppTec Revenue in First-in-Human (FIH) Services Business (2020-2025) & (US$ Million)
Table 50. WuXi AppTec Recent Development
Table 51. Allucent Company Details
Table 52. Allucent Business Overview
Table 53. Allucent First-in-Human (FIH) Services Product
Table 54. Allucent Revenue in First-in-Human (FIH) Services Business (2020-2025) & (US$ Million)
Table 55. Allucent Recent Development
Table 56. Altasciences Company Details
Table 57. Altasciences Business Overview
Table 58. Altasciences First-in-Human (FIH) Services Product
Table 59. Altasciences Revenue in First-in-Human (FIH) Services Business (2020-2025) & (US$ Million)
Table 60. Altasciences Recent Development
Table 61. LAXAI Company Details
Table 62. LAXAI Business Overview
Table 63. LAXAI First-in-Human (FIH) Services Product
Table 64. LAXAI Revenue in First-in-Human (FIH) Services Business (2020-2025) & (US$ Million)
Table 65. LAXAI Recent Development
Table 66. Lonza Company Details
Table 67. Lonza Business Overview
Table 68. Lonza First-in-Human (FIH) Services Product
Table 69. Lonza Revenue in First-in-Human (FIH) Services Business (2020-2025) & (US$ Million)
Table 70. Lonza Recent Development
Table 71. Syneos Health Company Details
Table 72. Syneos Health Business Overview
Table 73. Syneos Health First-in-Human (FIH) Services Product
Table 74. Syneos Health Revenue in First-in-Human (FIH) Services Business (2020-2025) & (US$ Million)
Table 75. Syneos Health Recent Development
Table 76. CD BioSciences Company Details
Table 77. CD BioSciences Business Overview
Table 78. CD BioSciences First-in-Human (FIH) Services Product
Table 79. CD BioSciences Revenue in First-in-Human (FIH) Services Business (2020-2025) & (US$ Million)
Table 80. CD BioSciences Recent Development
Table 81. Fortrea Company Details
Table 82. Fortrea Business Overview
Table 83. Fortrea First-in-Human (FIH) Services Product
Table 84. Fortrea Revenue in First-in-Human (FIH) Services Business (2020-2025) & (US$ Million)
Table 85. Fortrea Recent Development
Table 86. Certara Company Details
Table 87. Certara Business Overview
Table 88. Certara First-in-Human (FIH) Services Product
Table 89. Certara Revenue in First-in-Human (FIH) Services Business (2020-2025) & (US$ Million)
Table 90. Certara Recent Development
Table 91. Evotec Company Details
Table 92. Evotec Business Overview
Table 93. Evotec First-in-Human (FIH) Services Product
Table 94. Evotec Revenue in First-in-Human (FIH) Services Business (2020-2025) & (US$ Million)
Table 95. Evotec Recent Development
Table 96. Aixial Group Company Details
Table 97. Aixial Group Business Overview
Table 98. Aixial Group First-in-Human (FIH) Services Product
Table 99. Aixial Group Revenue in First-in-Human (FIH) Services Business (2020-2025) & (US$ Million)
Table 100. Aixial Group Recent Development
Table 101. Quotient Sciences Company Details
Table 102. Quotient Sciences Business Overview
Table 103. Quotient Sciences First-in-Human (FIH) Services Product
Table 104. Quotient Sciences Revenue in First-in-Human (FIH) Services Business (2020-2025) & (US$ Million)
Table 105. Quotient Sciences Recent Development
Table 106. Sofpromed Company Details
Table 107. Sofpromed Business Overview
Table 108. Sofpromed First-in-Human (FIH) Services Product
Table 109. Sofpromed Revenue in First-in-Human (FIH) Services Business (2020-2025) & (US$ Million)
Table 110. Sofpromed Recent Development
Table 111. Spaulding Clinical Company Details
Table 112. Spaulding Clinical Business Overview
Table 113. Spaulding Clinical First-in-Human (FIH) Services Product
Table 114. Spaulding Clinical Revenue in First-in-Human (FIH) Services Business (2020-2025) & (US$ Million)
Table 115. Spaulding Clinical Recent Development
Table 116. Biotrial Company Details
Table 117. Biotrial Business Overview
Table 118. Biotrial First-in-Human (FIH) Services Product
Table 119. Biotrial Revenue in First-in-Human (FIH) Services Business (2020-2025) & (US$ Million)
Table 120. Biotrial Recent Development
Table 121. Crystal Pharmatech Co., Ltd Company Details
Table 122. Crystal Pharmatech Co., Ltd Business Overview
Table 123. Crystal Pharmatech Co., Ltd First-in-Human (FIH) Services Product
Table 124. Crystal Pharmatech Co., Ltd Revenue in First-in-Human (FIH) Services Business (2020-2025) & (US$ Million)
Table 125. Crystal Pharmatech Co., Ltd Recent Development
Table 126. Avania Company Details
Table 127. Avania Business Overview
Table 128. Avania First-in-Human (FIH) Services Product
Table 129. Avania Revenue in First-in-Human (FIH) Services Business (2020-2025) & (US$ Million)
Table 130. Avania Recent Development
Table 131. Research Programs/Design for This Report
Table 132. Key Data Information from Secondary Sources
Table 133. Key Data Information from Primary Sources
Table 134. Authors List of This Report
List of Figures
Figure 1. First-in-Human (FIH) Services Picture
Figure 2. Global First-in-Human (FIH) Services Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global First-in-Human (FIH) Services Market Share by Type: 2024 VS 2031
Figure 4. Drugs Features
Figure 5. Medical Device Features
Figure 6. Global First-in-Human (FIH) Services Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global First-in-Human (FIH) Services Market Share by Application: 2024 VS 2031
Figure 8. Pharmaceutical Companies Case Studies
Figure 9. Contract Research Organizations (CROs) Case Studies
Figure 10. Academic Institutions and Research Centers Case Studies
Figure 11. Medical Device Companies Case Studies
Figure 12. First-in-Human (FIH) Services Report Years Considered
Figure 13. Global First-in-Human (FIH) Services Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global First-in-Human (FIH) Services Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global First-in-Human (FIH) Services Market Share by Region: 2024 VS 2031
Figure 16. Global First-in-Human (FIH) Services Market Share by Players in 2024
Figure 17. Global Top First-in-Human (FIH) Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in First-in-Human (FIH) Services as of 2024)
Figure 18. The Top 10 and 5 Players Market Share by First-in-Human (FIH) Services Revenue in 2024
Figure 19. North America First-in-Human (FIH) Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America First-in-Human (FIH) Services Market Share by Country (2020-2031)
Figure 21. United States First-in-Human (FIH) Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada First-in-Human (FIH) Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe First-in-Human (FIH) Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe First-in-Human (FIH) Services Market Share by Country (2020-2031)
Figure 25. Germany First-in-Human (FIH) Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France First-in-Human (FIH) Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. First-in-Human (FIH) Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy First-in-Human (FIH) Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia First-in-Human (FIH) Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Nordic Countries First-in-Human (FIH) Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific First-in-Human (FIH) Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific First-in-Human (FIH) Services Market Share by Region (2020-2031)
Figure 33. China First-in-Human (FIH) Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan First-in-Human (FIH) Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea First-in-Human (FIH) Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia First-in-Human (FIH) Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India First-in-Human (FIH) Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia First-in-Human (FIH) Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America First-in-Human (FIH) Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America First-in-Human (FIH) Services Market Share by Country (2020-2031)
Figure 41. Mexico First-in-Human (FIH) Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil First-in-Human (FIH) Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa First-in-Human (FIH) Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa First-in-Human (FIH) Services Market Share by Country (2020-2031)
Figure 45. Turkey First-in-Human (FIH) Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia First-in-Human (FIH) Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. UAE First-in-Human (FIH) Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. WuXi AppTec Revenue Growth Rate in First-in-Human (FIH) Services Business (2020-2025)
Figure 49. Allucent Revenue Growth Rate in First-in-Human (FIH) Services Business (2020-2025)
Figure 50. Altasciences Revenue Growth Rate in First-in-Human (FIH) Services Business (2020-2025)
Figure 51. LAXAI Revenue Growth Rate in First-in-Human (FIH) Services Business (2020-2025)
Figure 52. Lonza Revenue Growth Rate in First-in-Human (FIH) Services Business (2020-2025)
Figure 53. Syneos Health Revenue Growth Rate in First-in-Human (FIH) Services Business (2020-2025)
Figure 54. CD BioSciences Revenue Growth Rate in First-in-Human (FIH) Services Business (2020-2025)
Figure 55. Fortrea Revenue Growth Rate in First-in-Human (FIH) Services Business (2020-2025)
Figure 56. Certara Revenue Growth Rate in First-in-Human (FIH) Services Business (2020-2025)
Figure 57. Evotec Revenue Growth Rate in First-in-Human (FIH) Services Business (2020-2025)
Figure 58. Aixial Group Revenue Growth Rate in First-in-Human (FIH) Services Business (2020-2025)
Figure 59. Quotient Sciences Revenue Growth Rate in First-in-Human (FIH) Services Business (2020-2025)
Figure 60. Sofpromed Revenue Growth Rate in First-in-Human (FIH) Services Business (2020-2025)
Figure 61. Spaulding Clinical Revenue Growth Rate in First-in-Human (FIH) Services Business (2020-2025)
Figure 62. Biotrial Revenue Growth Rate in First-in-Human (FIH) Services Business (2020-2025)
Figure 63. Crystal Pharmatech Co., Ltd Revenue Growth Rate in First-in-Human (FIH) Services Business (2020-2025)
Figure 64. Avania Revenue Growth Rate in First-in-Human (FIH) Services Business (2020-2025)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Table 1. Global First-in-Human (FIH) Services Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Drugs
Table 3. Key Players of Medical Device
Table 4. Global First-in-Human (FIH) Services Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global First-in-Human (FIH) Services Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global First-in-Human (FIH) Services Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global First-in-Human (FIH) Services Market Share by Region (2020-2025)
Table 8. Global First-in-Human (FIH) Services Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global First-in-Human (FIH) Services Market Share by Region (2026-2031)
Table 10. First-in-Human (FIH) Services Market Trends
Table 11. First-in-Human (FIH) Services Market Drivers
Table 12. First-in-Human (FIH) Services Market Challenges
Table 13. First-in-Human (FIH) Services Market Restraints
Table 14. Global First-in-Human (FIH) Services Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global First-in-Human (FIH) Services Market Share by Players (2020-2025)
Table 16. Global Top First-in-Human (FIH) Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in First-in-Human (FIH) Services as of 2024)
Table 17. Ranking of Global Top First-in-Human (FIH) Services Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by First-in-Human (FIH) Services Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of First-in-Human (FIH) Services, Headquarters and Area Served
Table 20. Global Key Players of First-in-Human (FIH) Services, Product and Application
Table 21. Global Key Players of First-in-Human (FIH) Services, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global First-in-Human (FIH) Services Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global First-in-Human (FIH) Services Revenue Market Share by Type (2020-2025)
Table 25. Global First-in-Human (FIH) Services Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global First-in-Human (FIH) Services Revenue Market Share by Type (2026-2031)
Table 27. Global First-in-Human (FIH) Services Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global First-in-Human (FIH) Services Revenue Market Share by Application (2020-2025)
Table 29. Global First-in-Human (FIH) Services Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global First-in-Human (FIH) Services Revenue Market Share by Application (2026-2031)
Table 31. North America First-in-Human (FIH) Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America First-in-Human (FIH) Services Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America First-in-Human (FIH) Services Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe First-in-Human (FIH) Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe First-in-Human (FIH) Services Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe First-in-Human (FIH) Services Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific First-in-Human (FIH) Services Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific First-in-Human (FIH) Services Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific First-in-Human (FIH) Services Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America First-in-Human (FIH) Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America First-in-Human (FIH) Services Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America First-in-Human (FIH) Services Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa First-in-Human (FIH) Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa First-in-Human (FIH) Services Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa First-in-Human (FIH) Services Market Size by Country (2026-2031) & (US$ Million)
Table 46. WuXi AppTec Company Details
Table 47. WuXi AppTec Business Overview
Table 48. WuXi AppTec First-in-Human (FIH) Services Product
Table 49. WuXi AppTec Revenue in First-in-Human (FIH) Services Business (2020-2025) & (US$ Million)
Table 50. WuXi AppTec Recent Development
Table 51. Allucent Company Details
Table 52. Allucent Business Overview
Table 53. Allucent First-in-Human (FIH) Services Product
Table 54. Allucent Revenue in First-in-Human (FIH) Services Business (2020-2025) & (US$ Million)
Table 55. Allucent Recent Development
Table 56. Altasciences Company Details
Table 57. Altasciences Business Overview
Table 58. Altasciences First-in-Human (FIH) Services Product
Table 59. Altasciences Revenue in First-in-Human (FIH) Services Business (2020-2025) & (US$ Million)
Table 60. Altasciences Recent Development
Table 61. LAXAI Company Details
Table 62. LAXAI Business Overview
Table 63. LAXAI First-in-Human (FIH) Services Product
Table 64. LAXAI Revenue in First-in-Human (FIH) Services Business (2020-2025) & (US$ Million)
Table 65. LAXAI Recent Development
Table 66. Lonza Company Details
Table 67. Lonza Business Overview
Table 68. Lonza First-in-Human (FIH) Services Product
Table 69. Lonza Revenue in First-in-Human (FIH) Services Business (2020-2025) & (US$ Million)
Table 70. Lonza Recent Development
Table 71. Syneos Health Company Details
Table 72. Syneos Health Business Overview
Table 73. Syneos Health First-in-Human (FIH) Services Product
Table 74. Syneos Health Revenue in First-in-Human (FIH) Services Business (2020-2025) & (US$ Million)
Table 75. Syneos Health Recent Development
Table 76. CD BioSciences Company Details
Table 77. CD BioSciences Business Overview
Table 78. CD BioSciences First-in-Human (FIH) Services Product
Table 79. CD BioSciences Revenue in First-in-Human (FIH) Services Business (2020-2025) & (US$ Million)
Table 80. CD BioSciences Recent Development
Table 81. Fortrea Company Details
Table 82. Fortrea Business Overview
Table 83. Fortrea First-in-Human (FIH) Services Product
Table 84. Fortrea Revenue in First-in-Human (FIH) Services Business (2020-2025) & (US$ Million)
Table 85. Fortrea Recent Development
Table 86. Certara Company Details
Table 87. Certara Business Overview
Table 88. Certara First-in-Human (FIH) Services Product
Table 89. Certara Revenue in First-in-Human (FIH) Services Business (2020-2025) & (US$ Million)
Table 90. Certara Recent Development
Table 91. Evotec Company Details
Table 92. Evotec Business Overview
Table 93. Evotec First-in-Human (FIH) Services Product
Table 94. Evotec Revenue in First-in-Human (FIH) Services Business (2020-2025) & (US$ Million)
Table 95. Evotec Recent Development
Table 96. Aixial Group Company Details
Table 97. Aixial Group Business Overview
Table 98. Aixial Group First-in-Human (FIH) Services Product
Table 99. Aixial Group Revenue in First-in-Human (FIH) Services Business (2020-2025) & (US$ Million)
Table 100. Aixial Group Recent Development
Table 101. Quotient Sciences Company Details
Table 102. Quotient Sciences Business Overview
Table 103. Quotient Sciences First-in-Human (FIH) Services Product
Table 104. Quotient Sciences Revenue in First-in-Human (FIH) Services Business (2020-2025) & (US$ Million)
Table 105. Quotient Sciences Recent Development
Table 106. Sofpromed Company Details
Table 107. Sofpromed Business Overview
Table 108. Sofpromed First-in-Human (FIH) Services Product
Table 109. Sofpromed Revenue in First-in-Human (FIH) Services Business (2020-2025) & (US$ Million)
Table 110. Sofpromed Recent Development
Table 111. Spaulding Clinical Company Details
Table 112. Spaulding Clinical Business Overview
Table 113. Spaulding Clinical First-in-Human (FIH) Services Product
Table 114. Spaulding Clinical Revenue in First-in-Human (FIH) Services Business (2020-2025) & (US$ Million)
Table 115. Spaulding Clinical Recent Development
Table 116. Biotrial Company Details
Table 117. Biotrial Business Overview
Table 118. Biotrial First-in-Human (FIH) Services Product
Table 119. Biotrial Revenue in First-in-Human (FIH) Services Business (2020-2025) & (US$ Million)
Table 120. Biotrial Recent Development
Table 121. Crystal Pharmatech Co., Ltd Company Details
Table 122. Crystal Pharmatech Co., Ltd Business Overview
Table 123. Crystal Pharmatech Co., Ltd First-in-Human (FIH) Services Product
Table 124. Crystal Pharmatech Co., Ltd Revenue in First-in-Human (FIH) Services Business (2020-2025) & (US$ Million)
Table 125. Crystal Pharmatech Co., Ltd Recent Development
Table 126. Avania Company Details
Table 127. Avania Business Overview
Table 128. Avania First-in-Human (FIH) Services Product
Table 129. Avania Revenue in First-in-Human (FIH) Services Business (2020-2025) & (US$ Million)
Table 130. Avania Recent Development
Table 131. Research Programs/Design for This Report
Table 132. Key Data Information from Secondary Sources
Table 133. Key Data Information from Primary Sources
Table 134. Authors List of This Report
List of Figures
Figure 1. First-in-Human (FIH) Services Picture
Figure 2. Global First-in-Human (FIH) Services Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global First-in-Human (FIH) Services Market Share by Type: 2024 VS 2031
Figure 4. Drugs Features
Figure 5. Medical Device Features
Figure 6. Global First-in-Human (FIH) Services Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global First-in-Human (FIH) Services Market Share by Application: 2024 VS 2031
Figure 8. Pharmaceutical Companies Case Studies
Figure 9. Contract Research Organizations (CROs) Case Studies
Figure 10. Academic Institutions and Research Centers Case Studies
Figure 11. Medical Device Companies Case Studies
Figure 12. First-in-Human (FIH) Services Report Years Considered
Figure 13. Global First-in-Human (FIH) Services Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global First-in-Human (FIH) Services Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global First-in-Human (FIH) Services Market Share by Region: 2024 VS 2031
Figure 16. Global First-in-Human (FIH) Services Market Share by Players in 2024
Figure 17. Global Top First-in-Human (FIH) Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in First-in-Human (FIH) Services as of 2024)
Figure 18. The Top 10 and 5 Players Market Share by First-in-Human (FIH) Services Revenue in 2024
Figure 19. North America First-in-Human (FIH) Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America First-in-Human (FIH) Services Market Share by Country (2020-2031)
Figure 21. United States First-in-Human (FIH) Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada First-in-Human (FIH) Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe First-in-Human (FIH) Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe First-in-Human (FIH) Services Market Share by Country (2020-2031)
Figure 25. Germany First-in-Human (FIH) Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France First-in-Human (FIH) Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. First-in-Human (FIH) Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy First-in-Human (FIH) Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia First-in-Human (FIH) Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Nordic Countries First-in-Human (FIH) Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific First-in-Human (FIH) Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific First-in-Human (FIH) Services Market Share by Region (2020-2031)
Figure 33. China First-in-Human (FIH) Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan First-in-Human (FIH) Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea First-in-Human (FIH) Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia First-in-Human (FIH) Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India First-in-Human (FIH) Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia First-in-Human (FIH) Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America First-in-Human (FIH) Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America First-in-Human (FIH) Services Market Share by Country (2020-2031)
Figure 41. Mexico First-in-Human (FIH) Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil First-in-Human (FIH) Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa First-in-Human (FIH) Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa First-in-Human (FIH) Services Market Share by Country (2020-2031)
Figure 45. Turkey First-in-Human (FIH) Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia First-in-Human (FIH) Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. UAE First-in-Human (FIH) Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. WuXi AppTec Revenue Growth Rate in First-in-Human (FIH) Services Business (2020-2025)
Figure 49. Allucent Revenue Growth Rate in First-in-Human (FIH) Services Business (2020-2025)
Figure 50. Altasciences Revenue Growth Rate in First-in-Human (FIH) Services Business (2020-2025)
Figure 51. LAXAI Revenue Growth Rate in First-in-Human (FIH) Services Business (2020-2025)
Figure 52. Lonza Revenue Growth Rate in First-in-Human (FIH) Services Business (2020-2025)
Figure 53. Syneos Health Revenue Growth Rate in First-in-Human (FIH) Services Business (2020-2025)
Figure 54. CD BioSciences Revenue Growth Rate in First-in-Human (FIH) Services Business (2020-2025)
Figure 55. Fortrea Revenue Growth Rate in First-in-Human (FIH) Services Business (2020-2025)
Figure 56. Certara Revenue Growth Rate in First-in-Human (FIH) Services Business (2020-2025)
Figure 57. Evotec Revenue Growth Rate in First-in-Human (FIH) Services Business (2020-2025)
Figure 58. Aixial Group Revenue Growth Rate in First-in-Human (FIH) Services Business (2020-2025)
Figure 59. Quotient Sciences Revenue Growth Rate in First-in-Human (FIH) Services Business (2020-2025)
Figure 60. Sofpromed Revenue Growth Rate in First-in-Human (FIH) Services Business (2020-2025)
Figure 61. Spaulding Clinical Revenue Growth Rate in First-in-Human (FIH) Services Business (2020-2025)
Figure 62. Biotrial Revenue Growth Rate in First-in-Human (FIH) Services Business (2020-2025)
Figure 63. Crystal Pharmatech Co., Ltd Revenue Growth Rate in First-in-Human (FIH) Services Business (2020-2025)
Figure 64. Avania Revenue Growth Rate in First-in-Human (FIH) Services Business (2020-2025)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Electrolytes for Lithium-Ion Batteries Market Research Report 2025
Jul 14, 25
Global Vanadium Products Market Research Report 2025
Jul 14, 25
Global High-purity Vanadium Oxide Market Research Report 2025
Jul 14, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232